Endovascular trials in ischemic stroke: an update

 

REPORT FROM THE 67TH AMERICAN ACADEMY OF NEUROLOGY (AAN) ANNUAL MEETING – WASHINGTON DC, APRIL 18-25, 2015 – The use of tissue plasminogen activators (tPA) in patients with ischemic stroke is limited by the narrow therapeutic time window, and poor efficacy in opening proximal occlusions of the major intracranial arteries. Intraarterial interventions, such as thrombectomy with mechanical devices, are potentially useful but studies to date have produced mixed results, in large part because of trial design and patient selection.

It takes 30 seconds

Recommend to a Colleague

Related Posts

Go back to home page